Blood test may predict which cancer patients benefit from immunotherapy
Knowledge-focused
Recruiting now
This study aims to find out if measuring a protein called Galectin-3 in the blood can help predict how patients with certain cancers will respond to immunotherapy drugs (PD-1/PD-L1 inhibitors). Researchers will observe 300 adults with kidney, lung, liver, or bladder cancer who ar…
Sponsor: Daniel Keizman • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC